The Combined Use of Metformin and Methotrexate in Psoriasis Patients with Metabolic Syndrome

Table 5

Results of treatment in two groups according to the rate of PASI reduction after 3 months (n = 66).

Group	Result
	Very good	Good	Moderate	Medium	Bad/No effect
Experiment (n = 35)	10 (28.6%)	2 (5.7%)	8 (22.9%)	10 (28.6%)	5 (14.2%)
Control (n = 31)	0 (0%)	0 (0%)	17 (54.9%)	13 (41.9%)	1 (3.2%)
	<0.05

Note. After 3 months of treatment, in the study group, 34.3% of the patients achieved “very good” and “good” results, whereas the control group had no patients with good results or more (, Chi square test).